Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 22.54
+1.34 (6.32%)
At close: Mar 27, 2026
HKG:1877 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -875.17 | -1,281 | -2,283 | -2,386 | -720.91 |
Depreciation & Amortization | 295.39 | 315.57 | 315.4 | 293.65 | 248.98 |
Other Amortization | 22.87 | 11.5 | 17.12 | - | 15.93 |
Loss (Gain) From Sale of Assets | -35.26 | -12.78 | -29.41 | -27.01 | -0.81 |
Asset Writedown & Restructuring Costs | 42.02 | 0.94 | 0.52 | 9.03 | 0.03 |
Loss (Gain) From Sale of Investments | 49.21 | 71.23 | 75.19 | - | -65.75 |
Loss (Gain) on Equity Investments | - | - | - | 71.03 | - |
Stock-Based Compensation | - | - | - | 91.91 | - |
Provision & Write-off of Bad Debts | -3.05 | -14.67 | 18.34 | 0.05 | 0.36 |
Other Operating Activities | -10.38 | -10.02 | -178.56 | -515.11 | 7.55 |
Change in Accounts Receivable | 105.16 | 54.21 | -314.42 | 971.48 | -770.56 |
Change in Inventory | -53.11 | -159.27 | -32.45 | -136.39 | -154.82 |
Change in Accounts Payable | -128.07 | -415.29 | 262.67 | -479.57 | 702.33 |
Change in Unearned Revenue | - | - | - | 1.05 | - |
Change in Other Net Operating Assets | 72.1 | -10.67 | 19.01 | 330.62 | 195.05 |
Operating Cash Flow | -519.57 | -1,434 | -2,005 | -1,775 | -605.05 |
Capital Expenditures | -768.3 | -690.99 | -832.57 | -383.1 | -901.77 |
Sale of Property, Plant & Equipment | 13.02 | 1.87 | 4.1 | 0 | 0.01 |
Cash Acquisitions | 0.82 | - | - | 2.22 | - |
Divestitures | -20.92 | - | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -10.85 | - |
Investment in Securities | -846.76 | -257.19 | -207.9 | -104.24 | -1,045 |
Other Investing Activities | 41.42 | 53.53 | 103.19 | 28.35 | 28.95 |
Investing Cash Flow | -1,581 | -892.78 | -933.19 | -467.62 | -1,918 |
Long-Term Debt Issued | 3,579 | 2,307 | 977.1 | 840.36 | 500 |
Long-Term Debt Repaid | -2,436 | -1,214 | -533.78 | -154.26 | -828.36 |
Net Debt Issued (Repaid) | 1,143 | 1,093 | 443.32 | 686.1 | -328.36 |
Issuance of Common Stock | 939.58 | - | 152.59 | 3,812 | 2,122 |
Repurchase of Common Stock | - | -4 | -26.89 | - | - |
Common Dividends Paid | -94.33 | -73.79 | -38.23 | - | -16.69 |
Other Financing Activities | 241.39 | 7.81 | 181.03 | 144.64 | 889 |
Financing Cash Flow | 2,229 | 1,023 | 711.83 | 4,643 | 2,666 |
Foreign Exchange Rate Adjustments | -21.71 | 12.01 | 7.55 | 92.27 | -23.23 |
Net Cash Flow | 107.32 | -1,291 | -2,219 | 2,492 | 119.61 |
Free Cash Flow | -1,288 | -2,125 | -2,838 | -2,158 | -1,507 |
Free Cash Flow Margin | -51.55% | -109.06% | -188.85% | -148.50% | -37.44% |
Free Cash Flow Per Share | -1.28 | -2.16 | -2.88 | -2.35 | -1.69 |
Cash Interest Paid | - | - | - | 25.55 | - |
Cash Income Tax Paid | 76.55 | 78.6 | -65.42 | 107.13 | -43.19 |
Levered Free Cash Flow | -966.68 | -1,104 | -2,116 | -1,310 | -1,174 |
Unlevered Free Cash Flow | -919.94 | -1,072 | -2,098 | -1,292 | -1,160 |
Change in Working Capital | -5.19 | -514.68 | 59.85 | 687.19 | -90.44 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.